Innovation Support to UK H&LS businesses Terry O’Neill, Head of Health BIA Pulse 18th March 2019 

UK Research and Innovation Ecosystem (one part of the ecosystem) Academic Health Science Networks Dept for Business, Energy and Industrial Strategy Dept of Health MedTech and In Vitro Diagnostics Co-operatives National Institute for Health Research NHS England Office for Life Sciences BEIS OLS DoH UK Research & Innovation KTN Innovate UK Research Councils NHS (E, S, W, NI) NIHR AHSNs MICs NHS E 

Innovate UK ‘Connect’ Thematic Focus Knowledge Transfer Advisors Local Presence Global Connections 

KTN’s Mission (Who we are & why we exist) KTN is the UK’s innovation network. Our mission is to deliver economic growth. We connect people to speed up innovation, solve problems and find markets for new ideas. We bring together businesses, entrepreneurs, academics and funders to develop new products, processes and services. UK Economic Growth Businesses, Entrepreneurs and Investors KTN The UK’s Innovation Network Technologies, Inventions and Creativity 

KTN Objectives • Increase business led R&D • Facilitate exploitation of R&D to capture more UK value from innovation • Increase collaboration between businesses (B2B) & between businesses and the research base (B2R) for UK benefit • Be the strategic partner of choice for innovation networking • Provide breadth and depth of expertise for businesses looking to innovate 

Breadth of expertise Chemistry & IB Materials Agri-Food Health Manufacturing European & International Diversity Design & Innovation Access to Funding & Finance KT Advisers Communications Events Finance and Ops Emerging Tech Enabling Tech Creative & Digital Infrastructure Transport Complex Systems 

2017-18 Stats • ~ 3000 new introductions • 442 new collaborations • ~ 59500 newsletter subscribers • 383 events • ~ 26400 delegates • Biggest event ever (MRE 2018) in March 2018 

KTN Fit: Enabling “the World’s most innovative economy”* “…do more to address some of the frictions in the system to support collaboration and the flow of knowledge between research base and industry, accelerating the path to market.” *Industrial Strategy White Paper 2017 

KTN: UK-wide & Local -people 

UK Innovation Mapping KTN Landscape Maps 

Prevention of Disease Identification of Disease Treatment of Disease Public Health Vaccination Health Monitoring Non- specific Chronic Disease Acute Disease Medical Technology Lifestyle change/Wellness – often Digital Medicines What is Health 

KTN Support for Business • Access to grants (all relevant grants) and assets • Access to funding and finance (private finance) • Building the best consortium • Building the best application • Connecting through a supply chain (B2B, A and C) • Connecting across sectors and technologies • Signposting through innovation landscape • Awareness of new market opportunities • International innovation opportunities (Newton, Prosperity, Expert Missions) 

KTN Health Typical Month • Approx 50 business visits • 1-4 Innovate UK/KTN events (deep-dives, competition briefings, consortia building, community building) • Review of proposals • Leadership Council support (MMIP, but also IBLF, SBLC, AMLC, CGP, etc.) – Advanced Therapies Task Force • Government support – SBRI (EAHSN) – NIHR – MICs – NHSE – AHSNs – DAs – Scotland, Wales and Northern Ireland 

Integration Zone IUK IIIa. Product IVa. Market I. Concept II. Seed IIIb. IVb. Innovation Funding Integrated Public / Private Funding Strategy – Health Focus 1 2 3 4 5 6 7 8 9 H2020 Excellence in Science Societal Challenges Emerging & Enabling Technologies Health & Life Sciences Infrastructure Systems Manufacturing & Materials Open Programme Regional Growth Fund Scotland Smart & R&D HTCs HICF I4I Case Awards Managed Programmes IKCs Industrial CASE Awards FFF Day Job Angels VC Early-stage VC Family Offices CRG Companies Banks Leadership in KEITS Resp. Mode Research Industrial Strategy Challenge Fund UKRI 

Commit to reach 2.4% of GDP investment in R&D by 2027 Industrial Strategy Challenge Fund 

Industrial Strategy Challenge Fund AI and Data Economy Healthy ageing Clean growth Future of mobility 

No content

KTN Support “KTN’s knowledge from the start has been both deep and broad. Nobody else has that complete knowledge and overview.” - Ian McCubbin, Past Chair, Medicines Manufacturing Partnership and Senior Vice- President GlaxoSmithKline 

Recent Feedback from KTN Evaluation • Adds value as a “free, neutral, and importantly trusted organisation” with a “national reach” • Overall “package of support” is “a key strength” • Most useful interactions (in correlation with impacts) were: – Speaking with a KTN expert – Attending a KTN event – Participating in a Special Interest Group • “KTN also generates important strategic outcomes, in particular improving the policy and strategic landscape for business-led innovation” SQW evaluation with 500 businesses in late 2017 

Reaching ambitious businesses • Connect, engage and catalyse new collaborations • Digital reach and self-help tools • Networking of networks Convening for impact • Working with leadership groups • Special interest groups Connecting research excellence • Knowledge transfer advisers • Special Interest Groups • KTP Cross-sector intelligence • Networking of networks • Analysis and intelligence • Special Interest groups Informing strategy Connecting needs and capabilities Capturing value from our research base Tackling the Grand Challenges Innovation in businesses and innovation in networking